Sackmann-Muriel, F <br/><br/>
Results of treatment with an intensive induction regimen using idarubicin in combination with cytarabine and etoposide in children with acute myeloblastic leukemia.  [electronic resource] 

 -  Leukemia research   
 - 973-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0145-2126 
<br/><br/><label>Standard No.: </label>10.1016/s0145-2126(96)00071-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Child<br/>Child, Preschool<br/>Cytarabine--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Idarubicin--administration & dosage<br/>Infant<br/>Leukemia, Myeloid--drug therapy<br/>Life Tables<br/>Male<br/>Prospective Studies<br/>Remission Induction<br/>Treatment Outcome